A framework to guide dose & regimen strategy for clinical drug development
Abstract Optimizing new drug therapies remains a challenge for clinical development, despite the use of ever more sophisticated quantitative methodologies. Although conceptually simple, the idea of finding the right treatment at the right dose for the right patient to ensure an appropriate balance o...
Guardado en:
Autores principales: | Oliver Sander, Baldur Magnusson, Inga Ludwig, Astrid Jullion, Christophe Meille, Daniel Lorand, Björn Bornkamp, Markus Hinder, Steven J. Kovacs, Michael Looby |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/15d1549b9b844cf58ce62297612b8cf4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A framework for economic evaluation of therapeutic drug monitoring—guided dosing in oncology
por: Daniel Erku, et al.
Publicado: (2021) -
Evaluation framework to guide implementation of AI systems into healthcare settings
por: Enrico Coiera, et al.
Publicado: (2021) -
Optimization of Initial Dose Regimen for Sirolimus in Pediatric Patients With Lymphangioma
por: Xiao Chen, et al.
Publicado: (2021) -
Computed tomography-guided core needle biopsy for lung nodules: low-dose versus standard-dose protocols
por: Yi-Yang Huang, et al.
Publicado: (2021) -
Regimen simplification and medication adherence: Fixed-dose versus loose-dose combination therapy for type 2 diabetes.
por: Anna-Katharina Böhm, et al.
Publicado: (2021)